These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37421212)

  • 1. Ruthenium polypyridine complexes containing prenyl groups as antibacterial agents against Staphylococcus aureus through a membrane-disruption mechanism.
    Wang R; Zhou X; Chen J; Chen Y; Xiong Y; Duan X; Liao X; Wang J
    Arch Pharm (Weinheim); 2023 Sep; 356(9):e2300175. PubMed ID: 37421212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of ruthenium polypyridine complexes with benzyloxyl groups and their antibacterial activities against Staphylococcus aureus.
    Wang R; Wei M; Wang X; Chen Y; Xiong Y; Cheng J; Tan Y; Liao X; Wang J
    J Inorg Biochem; 2022 Nov; 236():111954. PubMed ID: 35988386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of ruthenium complexes bearing the 1,2,4-triazole group as potential membrane-targeting antibacterial agents towards
    Wang P; Huang HY; Dou LX; Deng W; Wang JT; Liao XW; Yu RJ; Duan XM; Xiong YS
    Dalton Trans; 2023 Jun; 52(25):8737-8746. PubMed ID: 37313713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-target antibacterial mechanism of ruthenium polypyridine complexes with anthraquinone groups against
    Jiang L; Ma Y; Chen Y; Cai M; Wu Z; Xiong Y; Duan X; Liao X; Wang J
    RSC Med Chem; 2023 Apr; 14(4):700-709. PubMed ID: 37122548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of ruthenium polypyridine complexes with 18β-glycyrrhetinic acid as antibacterial agents against
    Zhang Q; Xiong Y; Cheng J; Tan Y; Liao X; Wang J
    Dalton Trans; 2022 Jan; 51(3):1099-1111. PubMed ID: 34935812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of aryl-thioether ruthenium polypyridine complexes: A multi-target antimicrobial agents against gram-positive bacteria.
    ChunYan Z; RuJian Y; LiQiang W; HaiYan H; JinTao W; XiangWen L; XueMin D; YanShi X
    Eur J Med Chem; 2022 Oct; 240():114562. PubMed ID: 35777103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium polypyridine complexes with triphenylamine groups as antibacterial agents against
    Jiang L; Ma Y; Xiong Y; Tan Y; Duan X; Liao X; Wang J
    Front Chem; 2022; 10():1035741. PubMed ID: 36300021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ruthenium (II) complexes with furan-substituted ligands as possible antibacterial agents against Staphylococcus aureus.
    Liao X; Wang J; Jiang G; Lingyu M; Jiang G; Wang J; Huang B
    Chem Biol Drug Des; 2021 Nov; 98(5):885-893. PubMed ID: 34453495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of ruthenium polypyridyl complexes against Staphylococcus aureus and biofilms.
    Bu S; Jiang G; Jiang G; Liu J; Lin X; Shen J; Xiong Y; Duan X; Wang J; Liao X
    J Biol Inorg Chem; 2020 Aug; 25(5):747-757. PubMed ID: 32564223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of ruthenium complexes functionalized with benzothiophene and their antibacterial activity against Staphylococcus aureus.
    Liao X; Liu L; Tan Y; Jiang G; Fang H; Xiong Y; Duan X; Jiang G; Wang J
    Dalton Trans; 2021 Apr; 50(16):5607-5616. PubMed ID: 33908929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of ruthenium complexes containing phenylseleny against Gram-positive bacterial infection by damage membrane integrity and avoid drug-resistance.
    Huang HY; Wang Q; Zhang CY; Chen ZX; Wang JT; Liao XW; Yu RJ; Xiong YS
    J Inorg Biochem; 2023 May; 242():112175. PubMed ID: 36898296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, anti-infective potency and mechanism study of novel Ru-based complexes containing substituted adamantane as antibacterial agents.
    Wang L; Liu L; Zhang C; Yu G; Lin W; Duan X; Xiong Y; Jiang G; Wang J; Liao X
    Eur J Med Chem; 2024 Apr; 270():116378. PubMed ID: 38604098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypyridyl ruthenium complexes with benzothiazole moiety as membrane disruptors and anti-resistance agents for Staphylococcus aureus.
    Deng W; Zhang CY; Dou LX; Huang LT; Wang JT; Liao XW; Wang LP; Yu RJ; Xiong YS
    J Inorg Biochem; 2024 May; 254():112517. PubMed ID: 38460482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
    Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin-modified ruthenium complexes by disrupting bacterial membrane to combat Gram-positive bacterial infection.
    Huang HY; Wang P; Deng W; Dou LX; Liao XW; Wang JT; Duan XM; Yu RJ; Xiong YS
    Dalton Trans; 2023 Jul; 52(28):9757-9771. PubMed ID: 37395360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2-Pyridyl-1,2,3-triazole "Click" Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA).
    Kumar SV; Scottwell SØ; Waugh E; McAdam CJ; Hanton LR; Brooks HJ; Crowley JD
    Inorg Chem; 2016 Oct; 55(19):9767-9777. PubMed ID: 27657170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium(II) complexes targeting membrane as biofilm disruptors and resistance breakers in Staphylococcus aureus bacteria.
    Wang L; Liu L; Wang X; Tan Y; Duan X; Zhang C; Cheng J; Xiong Y; Jiang G; Wang J; Liao X
    Eur J Med Chem; 2022 Aug; 238():114485. PubMed ID: 35635951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.